BNP Paribas Financial Markets
LONA

BNP Paribas Financial Markets’s LeonaBio Inc LONA Stock Holding History

BNP Paribas Financial Markets’s Portfolio LONA Stock Details LONA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$236 Hold
23
– – ﹤0.01% 5614
2025
Q4 		$174 Hold
23
– – ﹤0.01% 5578
2025
Q3 		$95 Sell
23
-117
-84% -$459 ﹤0.01% 5438
2025
Q2 		$422 Buy
140
+4
+3% +$11 ﹤0.01% 5234
2025
Q1 		$388 Hold
136
– – ﹤0.01% 5161
2024
Q4 		$798 Buy
+136
New +$767 ﹤0.01% 5112

Other funds holding LONA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
SSC
Spruce Street Capital New York $416M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SFCM
Seven Fleet Capital Management Mountain View, California $318M AUM

BNP Paribas Financial Markets's LONA Position: Q1 2026 in Review

BNP Paribas Financial Markets held its LeonaBio Inc (LONA) position steady in Q1 2026 at 23 shares worth $236. The position accounts for ﹤0.01% of the portfolio, ranked #5614.

BNP Paribas Financial Markets first reported a position in LONA in Q4 2024 and has held it in 6 quarters since. The position peaked at $798 in Q4 2024. 40 funds tracked by Wall St. Rank hold LONA as of Q1 2026.

  • BNP Paribas Financial Markets held 23 shares of LeonaBio Inc worth $236 as of Q1 2026.
  • BNP Paribas Financial Markets left its LeonaBio Inc share count unchanged in Q1 2026.
  • LeonaBio Inc made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #5614 holding.
  • BNP Paribas Financial Markets first reported a position in LeonaBio Inc in Q4 2024 and has held it in 6 quarters since.
  • BNP Paribas Financial Markets's LeonaBio Inc position peaked at $798 in Q4 2024.
  • 40 funds tracked by Wall St. Rank held LeonaBio Inc as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.